Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP

Ital J Pediatr. 2023 Jan 26;49(1):15. doi: 10.1186/s13052-023-01418-7.


Around the world, the 2019 Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has raised serious public health problems and major medical challenges. The Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) published several papers on the impact of COVID-19 on the current management, diagnosis, and treatment of acute and chronic gastrointestinal, hepatic, immune-mediated, and functional disorders. The present article summarizes the most relevant SIGENP reports and consensus during and after the peak of the COVID-19 outbreak, including the diagnosis and treatment of inflammatory bowel disease (IBD), indications and timing of digestive endoscopy, and insights into the novel hepatitis.

Keywords: Anti-TNF-α; COVID-19; Digestive endoscopy; Hepatitis; Inflammatory bowel disease; Liver disease; Pediatrics; SARS-CoV-2; SIGENP; Telemedicine.

Publication types

  • Review

MeSH terms

  • COVID-19*
  • Child
  • Gastroenterology*
  • Humans
  • Inflammatory Bowel Diseases* / therapy
  • Italy / epidemiology
  • Liver Diseases* / diagnosis
  • Liver Diseases* / epidemiology
  • Liver Diseases* / therapy
  • SARS-CoV-2